Cargando…

Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer

BACKGROUND: The carcinogenesis of colorectal cancer (CRC) involves many different molecules and multiple pathways, and the specific mechanism has not been elucidated until now. Existing studies on the proteomic signature profiles of CRC are relatively limited. Therefore, we herein aimed to provide a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qian-Qian, Zhou, Yuan-Chen, Zhou Ge, Yu-Jia, Qin, Geng, Yin, Teng-Fei, Zhao, Dong-Yan, Tan, Chang, Yao, Shu-Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Case Control Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372836/ https://www.ncbi.nlm.nih.gov/pubmed/36158487 http://dx.doi.org/10.12998/wjcc.v10.i22.7686

Ejemplares similares

Proteomics-based identification of proteins in tumor-derived exosomes as candidate biomarkers for colorectal cancer
por: Zhou, Ge-Yu-Jia, et al.
Publicado: (2023)

Leukocyte immunoglobulin-like receptor B2 overexpression as a promising therapeutic target and noninvasive screening biomarker for colorectal cancer
por: Wang, Qian-Qian, et al.
Publicado: (2023)

Circulating miR-627-5p and miR-199a-5p are promising diagnostic biomarkers of colorectal neoplasia
por: Zhao, Dong-Yan, et al.
Publicado: (2022)

Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer
por: Sun, Xi-Zhen, et al.
Publicado: (2020)

Serum neuron-specific enolase: A promising biomarker of silicosis
por: Huang, Hong-Bo, et al.
Publicado: (2021)

Comprehensive Proteomic Characterization of the Human Colorectal Carcinoma Reveals Signature Proteins and Perturbed Pathways
por: Hao, Jian-Jiang, et al.
Publicado: (2017)

Identification of circ_0000375 and circ_0011536 as novel diagnostic biomarkers of colorectal cancer
por: Yin, Teng-Fei, et al.
Publicado: (2022)

Identification of the circRNA-miRNA-mRNA regulatory network and its prognostic effect in colorectal cancer
por: Yin, Teng-Fei, et al.
Publicado: (2021)

A serum piRNA signature as promising non-invasive diagnostic and prognostic biomarkers for colorectal cancer
por: Qu, Ailin, et al.
Publicado: (2019)

Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma
por: Rao, Qian‐Wen, et al.
Publicado: (2020)

MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer
por: Cheng, Lin-Yao, et al.
Publicado: (2022)

Identification of an 11-Autophagy-Related-Gene Signature as Promising Prognostic Biomarker for Bladder Cancer Patients
por: Zhou, Chaoting, et al.
Publicado: (2021)

Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma
por: Malik, Juliane, et al.
Publicado: (2022)

Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis
por: Zang, Xiao, et al.
Publicado: (2015)

Prognostic circulating proteomic biomarkers in colorectal liver metastases
por: Kim, Dongchan, et al.
Publicado: (2023)

The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis
por: Xing, X, et al.
Publicado: (2013)

Comprehensive Analysis Revealed that CDKN2A is a Biomarker for Immune Infiltrates in Multiple Cancers
por: Chen, Zheng, et al.
Publicado: (2021)

CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Luo, Jun-peng, et al.
Publicado: (2021)

Bikunin: A Promising Prognostic Biomarker for Acute-on-Chronic Liver Failure in Patients with Viral Hepatitis B
por: Qin, Gang, et al.
Publicado: (2023)

Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma
por: Zhang, Qifan, et al.
Publicado: (2021)

microRNA-627-5p inhibits colorectal cancer cell proliferation, migration and invasion by targeting Wnt2
por: Zhao, Dong-Yan, et al.
Publicado: (2023)

Comprehensive Transcriptomic Analysis Reveals Prognostic Value of an EMT-Related Gene Signature in Colorectal Cancer
por: Mo, Shaobo, et al.
Publicado: (2021)

Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer
por: Kang, Ning, et al.
Publicado: (2022)

Correction: CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
Publicado: (2022)

Promise and Implementation of Proteomic Prostate Cancer Biomarkers
por: Latosinska, Agnieszka, et al.
Publicado: (2018)

The Development of Three-DNA Methylation Signature as a Novel Prognostic Biomarker in Patients with Colorectal Cancer
por: Gong, Shu, et al.
Publicado: (2020)

Promising Clinical Applications of Hydrogels Associated With Precise Cancer Treatment: A Review
por: Wang, Qian-qian, et al.
Publicado: (2023)

Comprehensive Analysis of the Prognostic Value and Immune Infiltrates of the Three-m5C Signature in Colon Carcinoma
por: Geng, Qishun, et al.
Publicado: (2021)

Non-invasive prognostic protein biomarker signatures associated with colorectal cancer
por: Surinova, Silvia, et al.
Publicado: (2015)

A novel 4-gene prognostic signature for hypermutated colorectal cancer
por: Ge, Weiting, et al.
Publicado: (2019)

COMPREHENSIVE MULTIPLATFORM ANALYSIS OF CDKN2A ALTERATIONS IN MENINGIOMAS
por: Wang, Justin Z, et al.
Publicado: (2023)

Comprehensive analysis of gene regulation network and immune signatures of prognostic biomarker YAP1 in pancreatic cancer
por: Yang, Yuan, et al.
Publicado: (2020)

Fecal microbial biomarkers combined with multi-target stool DNA test improve diagnostic accuracy for colorectal cancer
por: Fan, Jin-Qing, et al.
Publicado: (2023)

MicroRNA Biomarkers as Promising Tools for Early Colorectal Cancer Screening—A Comprehensive Review
por: Santos, Daniela A. R., et al.
Publicado: (2023)

TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia
por: Zhang, Wei, et al.
Publicado: (2023)

The Promise of Biomarkers in Colorectal Cancer Detection
por: Umar, Asad, et al.
Publicado: (2004)

Age-Associated Proteomic Signatures and Potential Clinically Actionable Targets of Colorectal Cancer
por: Gong, Yanqiu, et al.
Publicado: (2021)

Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer
por: Li, Chen, et al.
Publicado: (2016)

Identification and Comprehensive Analysis of FREM2 Mutation as a Potential Prognostic Biomarker in Colorectal Cancer
por: Du, Hanpeng, et al.
Publicado: (2022)

Comprehensive genomic profiling reveals prognostic signatures and insights into the molecular landscape of colorectal cancer
por: Yang, Jinwei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o2h9lalat4sj332g08dv7sgs5u